Evaluation of the time since the occurrence of stroke incident to medical assistance provision in the population of the Świętokrzyskie region
Keywords:
stroke, time, effects, survival chain, 90 gold minutesAbstract
Introduction. Stroke is a disease which can be prevented, but in the case of getting ill, specialist and therapeutic actions can ensure the minimization of the effects of the disease.
A lot of patients and their close ones don’t know how to recognize the symptoms of stroke and aren’t aware that the illness needs immediate treatment.
The definition „time is brain” should be understood by all of the engaged in the „stroke chain of survival”
Aim. The aim of the study was to evaluate the time period between the occurrence of stroke and the admittance of patients to the neurological health care facility in Ostrowiec Swietokrzyski.
Material and methods: The examination covered 381 people. The material was obtained based on a review of the patients’ documentation, and in conclusion the results of Chi^2 Pearson test were used.
Results. Among the examined population there were 52% of women and 48% of men. In the investigation five categories of time were considered (>5,5h, 4-5,5h, 4-2,5h, 2-2,5h and <2h).
The obtained results show that during 90 „gold minutes” 18.11% of the examined asked for help and in 4.5 hrs. 11.29% of patients referred to the hospital. Still 72.18% of the respondents found themselves beyond time warranting a chance of life saving.
Conclusions. Too long period of time
References
1. Kozubski W., Liberski P.P.(red). Choroby układu nerwowego. PZWL Warszawa 2004.
2. Ryglewicz D., Wiszniewska M., Cichy S. i wsp. Ischaemic strokes are more serve in Poland then in the United States. Neurology 2000, 54, 513-515.
3. Czarnecka D., Zabojszcz M., Nadciśnienie tętnicze, a udar mózgu. Choroby Serca i Naczyń 2004: 1, 1: 19–25.
4. Becker K., Fruin M., Gooding T., Tirschwell D., Love P., Mankowski T. Community-based education improves stroke knowledge. Cerebrovasc Diseases 2001; 11: 34–43.
5. Evenson K.R., Rosamond W.D., Morris D.L. Prehospital and inhospital delays in acute stroke care. Neuroepidemiology 2001; 20: 65–76.
6. Wein T.H., Staub L., Felberg R., Hickenbottom S.L., Chan W., Grotta J.C., Demchuck A.M., Groff J., Bartholomew L.K., Morgenstern L.B.: Activation of emergency medical services for acute stroke in a nonurban population: the TLL Temple Foundation Stroke Project. Stroke 2000; 31: 1925–1928.
7. Tissue plazminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-Pa Stroke Study Group. The New England Journal of Medicine 1995, 333: 1581-1587.
8. Kothari R., Hall K., Brott T., Broderick J. Early stroke recognition: developing and out-of-hospital NIH Stroke Scale. Academic Emergency Medicine 1997; 4: 986–990.
9. Kwan J., Sandercock P. In-hospital care pathways for stroke (Cochrane review). In: Cochrane Library, Issue 1, 2003. Update Software
10. Barber P.A., Zhang J., Demchuk A.M., Hill M.D., Buchan A.M.: Why are stroke patients excluded from TPA therapy? An analysis of patients eligibility. Neurology, 2001; 56: 1015–1020.
11. Derex L., Adeleine P., Nighoghossian N., Honnorat J., Trouillas P.: Factors influencing early admission in a French stroke unit. Stroke 2002; 33: 153–159.
12. Harraf F., Sharma A.K., Brown M.M., Lees K.R., Vass R.I., Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. BMJ Journal 2002; 325: 17
13. Thomas S.H., Kociszewski C., Schwamm L.H., Wedel S.K. The evolving role of helicopter emergency medical services in the transfer of stroke patients to specialized centers. Prehospital Emergency Care 2002; 6: 210–204.
14. Camerlingo M., Casto L., Censori B., Ferraro B., Gazzaniga G., Partziguian T., Signore M., Panagia C., Fascendini A., Cesana B.M., Mamoli A. Experience with a questionnaire administered by emergency medical service for pre-hospital identification of patients with acute stroke. Neurological Sciences 2001; 22: 357–361.
15. Kabayashi A., Członkowska A., Leczenie trombolityczne w udarze niedokrwiennym mózgu. Farmakoterapia w psychiatrii i neurologii. 2005; 1: 5-18.
16. Banecka-Majkutowicz Z., Nyka W.M., Analiza czynników ryzyka udaru niedokrwiennego mózgu. Udar mózgu 2002; 4, 1: 15-22.
17. Banecka- Majkutowicz Z., Dobkowska M., Wichowicz H. Analiza czynników ryzyka udaru niedokrwiennego. Ann Acad Med Gedan 2005; 35: 207- 216.
18. Blacher J., Asmar R. i wsp. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertensions 1999; 33: 1111-1117.
19. Naess H., Nyland H.I., Thornassen L., Aarseth J., Myhr K.M., Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population- based case-control study. European Journal of Neurology 2004, 11, s. 25-28.
Downloads
Published
Issue
Section
License
Copyright (c) 2011 Małgorzata Cichońska, Monika Borek, Wioletta Krawczyk, Dorota Maciąg, Joanna Iłżecka (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
